Quantum-Si Incorporated (NASDAQ: QSI), a proteomics technology company based in Branford, Connecticut, announced an expansion of its roadshow for the Proteus protein sequencing platform across the United States and Europe.
The expanded itinerary follows a June update on the program and precedes the platform’s commercial launch, though no specific date has been disclosed. The company plans to supplement the roadshow with five seminars hosted alongside academic, clinical research, and biopharma partners at various locations.
Scheduled stops include Leiden on September 11; Paris on September 14; London on September 15; the University of Colorado Anschutz Medical Campus on September 22; and New York on September 24.
Fourth-quarter events, conducted with local channel partners, will take place in Barcelona on October 14 and Rome on October 16. Additional November appearances are set for Munich on November 2 and Berlin on November 4.
"These engagements give us an important opportunity to demonstrate how Proteus is designed to expand access to single-molecule protein sequencing and to support continued customer education ahead of commercial launch," said Jeff Hawkins, Quantum-Si’s president and chief executive officer.
